Navigation Links
Clinical Innovation Outsourcing Awards Deadline Extension: Friday 2nd March
Date:2/29/2012

LONDON, February 29, 2012 /PRNewswire/ --

Due to the popular demand, Pharma IQ has extended the nomination deadline for the Clinical Innovation Outsourcing Award for Dynamic Leadership in the Pharma and Biotech Industry.

The Clinical Outsourcing Innovation Awards 2012 has been designed to highlight key achievements made by individual companies within the R&D industry that have improved efficiencies and furthered the definition of innovation. The award will be reviewed for Dynamic Leadership in the Pharma and Biotech Industry.

The Award nominees will be judged by the following criteria:

  • Impact to company, business or end user
  • Novelty, pursuit of entrepreneurship and industry best practice
  • Technical excellence, content, validity and applicability
  • Excellence in efficiency or improvements (cost cutting, improvement docs, service levels, patient safety, reduced risk, streamlined processes, etc)

Online voting will open this March allowing the community at large to vote. Additionally, there will be onsite voting at the Global Clinical Outsourcing Forum.

The delegation will have the opportunity to review the nominees and cast their vote. The awards presentation will be at the end of the first day of the Global Clinical Outsourcing Forum.

To enter the orders, one has to complete the nomination form and send it, along with supplementary information to support the nomination to Nicola Ambler at nicola.ambler@iqpc.co.uk. The nomination form can be obtained from the website: http://www.globalclinicaloutsourcing.com/Event.aspx?id=675738

The Clinical Innovation Outsourcing Award was designed as a part of the Global Clinical Outsourcing Forum, taking place 24-25 April, 2012 in Amsterdam. The event brings together 20 leading industry experts and is completely presentation free providing an interactive, discussion based forum for clinical outsourcing experts.

For more information about the event, please visit http://www.globalclinicaloutsourcing.com/NEWS, email: enquire@iqpc.co.uk or call +44(0)20-7036-1300

Media contact : Joanna Checinska, +44(0)20-7368-9421, joanna.checinska@iqpc.co.uk  - Please contact for more information or images.

Press are invited to attend this important industry forum, if you would like to a complimentary press pass please email Joanna Checinska (Joanna.checinska@iqpc.co.uk)


'/>"/>
SOURCE Pharma IQ
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Crothall Healthcare Introduces Clinical Equipment Solutions Division
2. OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma
3. Nektar Presents Positive Proof-of-Concept Clinical Data for Its New Opioid Molecule, NKTR-181, at American Academy of Pain Medicines 28th Annual Meeting
4. New Data Suggest Minimally Invasive, Video-Assisted Thorascopic Wedge Resections for Lung Cancer Provide Clinical and Economic Advantages to Patients, Hospitals and Payors
5. Preclinical Study Examines Use of nContacts Technology in Enabling a Percutaneous Device Approach to Epicardial Ablation
6. NW Bio Reaches 30 Clinical Trial Sites Ahead of End-of-Q1 Projection
7. Elsevier Integrates its Clinical Decision Support Solutions Into PatientKeeper CPOE
8. Acuo Technologies Updates the Universal Clinical Platform
9. Growing List of Providers Accelerate Revenue Cycles, Improve Clinical Documentation Through True Computer-Assisted Coding with Natural Language Comprehension™
10. Anthera Pharmaceuticals Reports 2011 Fourth Quarter Financial Results and Provides Clinical Progress Update
11. Inclinix, Inc. and JSW Life Sciences Announce Formal Strategic Partnership for European Clinical Trial Enrollment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2017)... and INDIANAPOLIS , June 9, 2017 ... with diabetes. In a further effort to help spread ... by this condition, the International Diabetes Federation (IDF) and ... have come together for the second phase of the ... programme (BRIDGES 2), reaffirming their commitment to helping people ...
(Date:6/7/2017)... June 7, 2017  Novavax, Inc., (Nasdaq: NVAX ... Phase 2 trials of its RSV F protein recombinant nanoparticle ... age have been published in the journal Vaccine ... shared in prior scientific conferences). The Company previously announced ... Novavax is developing the RSV F Vaccine with the goal ...
(Date:6/2/2017)... Mass. , June 2, 2017  NxStage Medical, ... renal care, today announced new findings demonstrating positive biochemical ... ® System One™. The data will be presented ... in Madrid, Spain . ... to Improve Home Dialysis Network in Europe ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... 2017 , ... The Aesthetic Channel has recently highlighted Dr. Ben Talei’s unique ... a proprietary technique that he calls the AuraLyft Facelift. The AuraLyft does ... patients can expect to look refreshed, rejuvenated, and revitalized. , Dr. Talei’s unique ...
(Date:6/23/2017)... Beach, FL (PRWEB) , ... June 23, 2017 , ... ... in Pinecrest, Florida. This is MD Now’s 28th facility overall and marks the urgent ... Dixie Highway, located one mile North of The Falls shopping mall. The new clinic ...
(Date:6/23/2017)... Francisco, CA (PRWEB) , ... June 23, 2017 , ... ... on 26th June, 2017 from 9 am to 3 pm to present to graduate ... The program is an original curriculum project led by The Health Improvement Service ...
(Date:6/23/2017)... ... 2017 , ... Radabaugh & Associates, a locally owned firm ... in North Central West Virginia, is embarking on a cooperative charity drive with ... the region. , The Stepping Stones organization offers a series of personal development ...
(Date:6/22/2017)... ... June 22, 2017 , ... United Benefit Advisors (UBA), the ... Company as its newest Partner Firm. Headquartered in Coconut Creek, Florida, Whipple & ... tailoring optimized benefit packages that strengthen the relationship between employer and employee. , ...
Breaking Medicine News(10 mins):